BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 23426089)

  • 1. Surveillance for hepatocellular carcinoma: how can we do better?
    Hassett M; Yopp AC; Singal AG
    Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue].
    Trinchet JC; Nahon P; Ganne-Carrie N
    Rev Prat; 2013 Feb; 63(2):222-5. PubMed ID: 23513790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for hepatocellular carcinoma.
    Sherman M
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):783-93. PubMed ID: 25260308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
    Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY
    Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
    [No Abstract]   [Full Text] [Related]  

  • 5. Surveillance for Hepatocellular Carcinoma.
    Marrero JA
    Clin Liver Dis; 2020 Nov; 24(4):611-621. PubMed ID: 33012448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Practice of Hepatocellular Carcinoma Surveillance.
    Loho IM; Siregar L; Waspodo AS; Hasan I
    Acta Med Indones; 2018 Oct; 50(4):353-360. PubMed ID: 30631003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
    Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
    PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.
    Kanwal F; Singal AG
    Gastroenterology; 2019 Jul; 157(1):54-64. PubMed ID: 30986389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.
    Parikh ND; Singal AG; Hutton DW; Tapper EB
    Am J Gastroenterol; 2020 Oct; 115(10):1642-1649. PubMed ID: 32530829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
    Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
    Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in surveillance and early diagnosis of hepatocellular carcinoma.
    Kim DY; Kim JW; Kuromatsu R; Ahn SH; Torimura T; Sherman M
    Oncology; 2011; 81 Suppl 1():56-60. PubMed ID: 22212937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.
    Atiq O; Tiro J; Yopp AC; Muffler A; Marrero JA; Parikh ND; Murphy C; McCallister K; Singal AG
    Hepatology; 2017 Apr; 65(4):1196-1205. PubMed ID: 27775821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
    Trevisani F; Santi V; Gramenzi A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
    Am J Gastroenterol; 2007 Nov; 102(11):2448-57; quiz 2458. PubMed ID: 17617210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States.
    Davila JA; Morgan RO; Richardson PA; Du XL; McGlynn KA; El-Serag HB
    Hepatology; 2010 Jul; 52(1):132-41. PubMed ID: 20578139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.
    Sinn DH; Yi J; Choi MS; Kim YJ; Gwak GY; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2015; 62(138):327-32. PubMed ID: 25916058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
    Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
    Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatocellular carcinoma surveillance].
    Costentin C
    Presse Med; 2017 Apr; 46(4):381-385. PubMed ID: 28081946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis.
    Sarasin FP; Giostra E; Hadengue A
    Am J Med; 1996 Oct; 101(4):422-34. PubMed ID: 8873514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
    El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
    Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.